TABLE I.
Compound | Indication |
---|---|
Tofacitinib | RA, PsA, UC |
Ruxolitinib | PCV, MF |
Baricitinib | RA |
Upadacitinib | RA |
Fedratinib | MF |
MF, Myelofibrosis; PCV, polycythemia vera; PsA, psoriatic arthritis; UC, ulcerative colitis.
Compound | Indication |
---|---|
Tofacitinib | RA, PsA, UC |
Ruxolitinib | PCV, MF |
Baricitinib | RA |
Upadacitinib | RA |
Fedratinib | MF |
MF, Myelofibrosis; PCV, polycythemia vera; PsA, psoriatic arthritis; UC, ulcerative colitis.